EGFR and neoplasm: No significant associations were observed between the groups positive and negative for the EGFR or K-Ras mutations with respect to proportions of predominant subtypes in the adenomatous component, the differentiation of the squamous component, lymphovascular invasion, clinical stages, or tumour sizes.